Roy Baynes Acquires Shares of Natera, Inc. (NTRA)
Roy Baynes purchased 1,646 shares of Natera, Inc. on June 26, 2026.
Key Points
- Roy Baynes bought 1,646 shares of Natera, Inc. on June 26, 2026, as part of an insider transaction.
- Shares of Natera, Inc. traded near $267.05 on Wednesday, with a market cap of $37.51 billion and a 52-week high of $271.47.
- Analysts from Guggenheim, Bernstein, and BTIG maintain a 'buy' rating for Natera, Inc., with price targets up to $310.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Roy Baynes, an insider at Natera, Inc., purchased 1,646 shares of the company on June 26, 2026. This transaction was not planned under a Rule 10b5-1 trading plan. Natera, Inc. trades on the NasdaqGS under the ticker NTRA.
Insider Buying and Selling at Natera, Inc.
On June 26, 2026, several insiders, including Roy Baynes, made purchases of Natera, Inc. shares. Baynes acquired 1,646 shares, while other insiders like Roelof Botha and Thomas Lynch Jr. also bought 1,691 and 1,905 shares, respectively. These transactions were direct purchases and not part of any prearranged plans.
Other Institutional Activity in Natera, Inc.
JPMorgan Chase & Co increased its holdings in Natera by 532,333 shares, bringing its total to 13,386,667 shares valued at approximately $2.5 billion, marking a 4.1% increase. Price T Rowe Associates also boosted its position by 1,312,887 shares, ending with 12,184,876 shares worth about $2.44 billion, reflecting a 12.1% increase. In contrast, BlackRock, Inc. trimmed its stake by 182,103 shares, now holding 10,677,338 shares valued at $2.14 billion, a 1.7% decrease.
Natera, Inc. Stock Down 13.7%
Shares of Natera, Inc. traded near $267.05 on Wednesday. The company has a market capitalization of $37.51 billion. Although it has a negative forward P/E ratio due to its unprofitability, it operates with a beta of 1.544, indicating somewhat higher volatility. The stock's 52-week range spans from $131.81 to $271.47, with moving averages at $212.40 (50-day) and $208.58 (200-day). Natera maintains a current ratio of 2.959 and a quick ratio of 2.697, showcasing its liquidity position.
$NTRA stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Natera, Inc. reported revenue of $2.5 billion, with a growth rate of 38.8%. Despite this, the company's net margin remains negative at -9.05%, and its return on equity is -15.02%. The next earnings release is scheduled for August 6, 2026.
Analysts Set New Price Targets
On June 29, 2026, Guggenheim maintained a 'buy' rating for Natera, Inc. with a price target of $290. Bernstein reiterated a 'buy' rating with a $310 target on June 26, while BTIG maintained its 'buy' stance with a target of $275 on June 24. Overall, the consensus among analysts is a 'strong buy' with a mean target price of $262.67 based on 21 opinions.
About Natera, Inc.
Natera, Inc. is a healthcare company based in Austin, Texas, specializing in diagnostics and research. It develops molecular testing services, including Signatera for cancer monitoring, and Panorama for prenatal testing. Led by CEO Steven Leonard Chapman, Natera employs over 6,100 people and partners with various laboratories and pharmaceutical companies worldwide.
Bottom Line
Roy Baynes' recent share purchase adds to the insider activity at Natera, Inc., reflecting ongoing interest in the company's future. Natera's stock remains a focus for both institutional investors and analysts, despite its current lack of profitability. These insider and institutional moves offer a glimpse into market sentiment, though they represent past actions and not necessarily current positions.
Get Natera, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NTRA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.